14-day Premium Trial Subscription Try For FreeGet Free
Date Action Amount Person Type
Jun 26, 2023 Sell 16 621 Kuhlmann Shirley R. Common Stock
Jun 26, 2023 Sell 1 363 Kuhlmann Shirley R. Common Stock
Jun 01, 2023 Sell 31 272 Ciaffoni Joseph Common Stock
Jun 02, 2023 Sell 30 272 Ciaffoni Joseph Common Stock
Jun 02, 2023 Sell 1 000 Ciaffoni Joseph Common Stock
May 30, 2023 Sell 31 271 Ciaffoni Joseph Common Stock
May 31, 2023 Sell 31 272 Ciaffoni Joseph Common Stock
May 18, 2023 Buy 9 792 Balice-gordon Rita J. Common Stock
May 18, 2023 Buy 9 792 Mcfarlane Neil F. Common Stock
May 18, 2023 Buy 9 792 Heffernan Michael Thomas Common Stock
May 18, 2023 Buy 9 792 Freund John Gordon Common Stock
May 18, 2023 Buy 9 792 Fallon John A. Common Stock
May 18, 2023 Buy 9 792 Melincoff Gwen A Common Stock
May 18, 2023 Buy 9 792 Santini Gino Common Stock
May 18, 2023 Buy 9 792 Bohlin Garen G Common Stock
Mar 15, 2023 Sell 31 640 Tupper Colleen Common Stock
Mar 01, 2023 Sell 13 324 Dreyer Scott Common Stock
Feb 10, 2023 Buy 31 185 Smith Thomas B Common Stock
Feb 10, 2023 Buy 25 739 Kuhlmann Shirley R. Common Stock
Feb 10, 2023 Sell 16 291 Kuhlmann Shirley R. Common Stock
Feb 10, 2023 Sell 7 755 Kuhlmann Shirley R. Common Stock
Feb 10, 2023 Buy 48 125 Kuhlmann Shirley R. Common Stock
Feb 13, 2023 Sell 21 811 Kuhlmann Shirley R. Common Stock
Feb 10, 2023 Buy 12 565 Tupper Colleen Common Stock
Feb 10, 2023 Sell 6 967 Tupper Colleen Common Stock
Feb 10, 2023 Sell 3 887 Tupper Colleen Common Stock
Feb 10, 2023 Buy 45 045 Tupper Colleen Common Stock
Feb 10, 2023 Buy 137 694 Ciaffoni Joseph Common Stock
Feb 10, 2023 Sell 44 121 Ciaffoni Joseph Common Stock
Feb 13, 2023 Buy 11 250 Ciaffoni Joseph Common Stock
Feb 10, 2023 Sell 59 736 Ciaffoni Joseph Common Stock
Feb 13, 2023 Sell 11 250 Ciaffoni Joseph Common Stock
Feb 10, 2023 Buy 117 500 Ciaffoni Joseph Common Stock
Feb 13, 2023 Sell 11 250 Ciaffoni Joseph Stock Option (Right to Purchase)
Feb 10, 2023 Buy 22 459 Dreyer Scott Common Stock
Feb 10, 2023 Sell 14 529 Dreyer Scott Common Stock
Feb 10, 2023 Sell 6 797 Dreyer Scott Common Stock
Feb 10, 2023 Buy 44 275 Dreyer Scott Common Stock
Jan 09, 2023 Sell 10 424 Dreyer Scott Common Stock
Jan 09, 2023 Sell 7 341 Dreyer Scott Common Stock
Jan 09, 2023 Sell 69 Dreyer Scott Common Stock
Dec 27, 2022 Buy 15 995 Heffernan Michael Thomas Common Stock
Dec 23, 2022 Buy 4 989 Heffernan Michael Thomas Common Stock
Dec 27, 2022 Buy 3 820 Heffernan Michael Thomas Common Stock
Dec 22, 2022 Buy 237 Heffernan Michael Thomas Common Stock
Dec 27, 2022 Sell 3 820 Heffernan Michael Thomas Common Stock
Dec 22, 2022 Sell 237 Heffernan Michael Thomas Stock Option (Right to Purchase)
Dec 23, 2022 Sell 4 989 Heffernan Michael Thomas Stock Option (Right to Purchase)
Dec 27, 2022 Sell 15 995 Heffernan Michael Thomas Stock Option (Right to Purchase)
Dec 27, 2022 Sell 3 820 Heffernan Michael Thomas Stock Option (Right to Purchase)
Dec 22, 2022 Sell 110 Ciaffoni Joseph Common Stock
Dec 23, 2022 Sell 147 Ciaffoni Joseph Common Stock
Dec 27, 2022 Sell 1 804 Ciaffoni Joseph Common Stock
Dec 27, 2022 Sell 400 Ciaffoni Joseph Common Stock
Dec 19, 2022 Sell 3 606 Heffernan Michael Thomas Stock Option (Right to Purchase)
Dec 21, 2022 Buy 46 600 Heffernan Michael Thomas Common Stock
Dec 20, 2022 Sell 33 758 Heffernan Michael Thomas Stock Option (Right to Purchase)
Dec 20, 2022 Buy 33 758 Heffernan Michael Thomas Common Stock
Dec 19, 2022 Buy 3 606 Heffernan Michael Thomas Common Stock
Dec 21, 2022 Sell 46 600 Heffernan Michael Thomas Common Stock
Dec 21, 2022 Sell 46 600 Heffernan Michael Thomas Stock Option (Right to Purchase)
Dec 19, 2022 Sell 1 134 Ciaffoni Joseph Common Stock
Dec 20, 2022 Sell 9 375 Ciaffoni Joseph Common Stock
Dec 21, 2022 Sell 7 333 Ciaffoni Joseph Common Stock
Dec 13, 2022 Buy 7 904 Heffernan Michael Thomas Common Stock
Dec 13, 2022 Buy 94 259 Heffernan Michael Thomas Common Stock
Dec 13, 2022 Buy 59 524 Heffernan Michael Thomas Common Stock
Dec 12, 2022 Buy 1 510 Heffernan Michael Thomas Common Stock
Dec 12, 2022 Buy 15 741 Heffernan Michael Thomas Common Stock
Dec 12, 2022 Buy 10 669 Heffernan Michael Thomas Common Stock
Dec 13, 2022 Sell 161 687 Heffernan Michael Thomas Common Stock
Dec 13, 2022 Sell 7 904 Heffernan Michael Thomas Stock Option (Right to Purchase)
Dec 01, 2022 Buy 76 653 Ciaffoni Joseph Common Stock
Dec 01, 2022 Sell 76 653 Ciaffoni Joseph Common Stock
Dec 02, 2022 Sell 54 400 Ciaffoni Joseph Common Stock
Dec 01, 2022 Sell 76 653 Ciaffoni Joseph Stock Option (Right to Purchase)
Nov 28, 2022 Buy 43 Ciaffoni Joseph Common Stock
Nov 28, 2022 Sell 43 Ciaffoni Joseph Common Stock
Nov 28, 2022 Sell 43 Ciaffoni Joseph Stock Option (Right to Purchase)
Nov 22, 2022 Buy 65 Ciaffoni Joseph Common Stock
Nov 22, 2022 Sell 65 Ciaffoni Joseph Common Stock
Nov 22, 2022 Sell 65 Ciaffoni Joseph Stock Option (Right to Purchase)
Nov 18, 2022 Buy 1 989 Ciaffoni Joseph Common Stock
Nov 18, 2022 Sell 1 989 Ciaffoni Joseph Common Stock
Nov 18, 2022 Sell 1 989 Ciaffoni Joseph Stock Option (Right to Purchase)
Oct 04, 2022 Sell 4 350 Tupper Colleen Common Stock
Sep 15, 2022 Sell 38 589 Kuhlmann Shirley R. Common Stock
Aug 11, 2022 Sell 300 Kuhlmann Shirley R. Common Stock
Jul 11, 2022 Sell 594 Dreyer Scott Common Stock
Jul 01, 2022 Sell 1 394 Ciaffoni Joseph Common Stock
May 19, 2022 Buy 14 035 Heffernan Michael Thomas Common Stock
May 19, 2022 Buy 14 035 Melincoff Gwen A Common Stock
May 19, 2022 Buy 14 035 Santini Gino Common Stock
May 19, 2022 Buy 14 035 Mcfarlane Neil F. Common Stock
May 19, 2022 Buy 14 035 Freund John Gordon Common Stock
May 19, 2022 Buy 14 035 Fallon John A. Common Stock
May 19, 2022 Buy 14 035 Bohlin Garen G Common Stock
May 19, 2022 Buy 14 035 Balice-gordon Rita J. Common Stock
Apr 06, 2022 Buy 17 845 Mcfarlane Neil F. Common Stock
Apr 06, 2022 Buy 0 Mcfarlane Neil F. No securities beneficially owned
INSIDER POWER
0.297
Last 100 transactions
Buy: 1 081 660 | Sell: 1 016 709 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be negative at a ratio of 0.297.

In total, the insiders bought 1 081 660 and sold 1 016 709 COLL shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Collegium Pharmaceutical

Collegium Pharmaceutical Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatm... COLL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT